Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille calmette-Guérin immunotherapy

Journal of Urology

Volumn 190, Issue 4, 2013, Pages 1192-1199

  Lee, Joo Yong ^a   Diaz, Richilda Red ^a   Cho, Kang Su ^a   Lim, Meng Shi ^e   Chung, Jae Seung ^c   Kim, Won Tae ^d   Ham, Won Sik ^a   Choi, Young Deuk ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Chungbuk National University College of Medicine   (South Korea)

^e SARAWAK GENERAL HOSPITAL   (Malaysia)

Author keywords

BCG vaccine; chlorin e6; photochemotherapy; treatment failure; urinary bladder neoplasms

Indexed keywords

BCG VACCINE; PHOTOSENSITIZING AGENT; RADACHLORIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLADDER BIOPSY; BLADDER IRRIGATION; CANCER IMMUNOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CYSTOSCOPE; CYSTOSCOPY; CYTOLOGY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MALE; NON MUSCLE INVASIVE BLADDER CANCER; PATIENT SAFETY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RECURRENT CANCER; TRANSURETHRAL RESECTION; TREATMENT OUTCOME;

5-ALA; 5-AMINOLEVULINIC ACID; ADVERSE EFFECT; AE; BACILLUS CALMETTE-GUÉRIN; BCG; BCG VACCINE; CARCINOMA IN SITU; CHLORIN E(6); CIS; HAL; HEXAMINOLEVULINIC ACID; LOWER URINARY TRACT SYMPTOMS; LUTS; NMIBC; NONMUSCLE INVASIVE BLADDER CANCER; PDT; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PPIX; PROTOPORPHYRIN IX; SAE; SERIOUS AE; TRANSURETHRAL BLADDER TUMOR RESECTION; TREATMENT FAILURE; TURB; URINARY BLADDER NEOPLASMS;

ADJUVANTS, IMMUNOLOGIC; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; CHLORINE COMPOUNDS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; PILOT PROJECTS; PROSPECTIVE STUDIES; TREATMENT FAILURE; URINARY BLADDER NEOPLASMS;

EID: 84883748618     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.04.077     Document Type: Article

References (30)

1. J.A. Garcia, and R. Dreicer Systemic chemotherapy for advanced bladder cancer: update and controversies J Clin Oncol 24 2006 5545
2. A. Bohle, D. Jocham, and P.R. Bock Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity J Urol 169 2003 90
3. J. Palou Redorta Management of BCG "failures" Eur Urol 49 2006 779
4. K.S. Han, and S.J. Hong Management of BCG failures in non-muscle-invasive bladder cancer Korean J Urol 50 2009 1037
5. J. Dunst, A. Diestelhorst, and R. Kuhn Organ-sparing treatment in muscle-invasive bladder cancer Strahlenther Onkol 181 2005 632
6. A. Juarranz, P. Jaén, and F. Sanz-Rodríguez Photodynamic therapy of cancer. Basic principles and applications Clin Transl Oncol 10 2008 148
7. T.J. Dougherty, C.J. Gomer, and B.W. Henderson Photodynamic therapy J Natl Cancer Inst 90 1998 889
8. J.H. Pinthus, A. Bogaards, and R. Weersink Photodynamic therapy for urological malignancies: past to current approaches J Urol 175 2006 1201
9. S. Douillard, D. Olivier, and T. Patrice In vitro and in vivo evaluation of Radachlorin(R) sensitizer for photodynamic therapy Photochem Photobiol Sci 8 2009 405
10. U.O. Nseyo, T.J. Dougherty, and L. Sullivan Photodynamic therapy in the management of resistant lower urinary tract carcinoma Cancer 60 1987 3113
11. L.S. Lee, P.S. Thong, and M. Olivo Chlorin e6-polyvinylpyrrolidone mediated photodynamic therapy - a potential bladder sparing option for high risk non-muscle invasive bladder cancer Photodiagnosis Photodyn Ther 7 2010 213
12. A. Donner, and M. Eliasziw Sample size requirements for reliability studies Stat Med 6 1987 441
13. G. Bozzini, P. Colin, and N. Betrouni Photodynamic therapy in urology: what can we do now and where are we heading? Photodiagnosis Photodyn Ther 9 2012 261
14. S.G. Kroeze, M.C. Grimbergen, and H. Rehmann Photodynamic therapy as novel nephron sparing treatment option for small renal masses J Urol 187 2012 289
15. C.M. Moore, D. Pendse, and M. Emberton Photodynamic therapy for prostate cancer - a review of current status and future promise Nat Clin Pract Urol 6 2009 18
16. N. Lange, P. Jichlinski, and M. Zellweger Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study Br J Cancer 80 1999 185
17. U.O. Nseyo, B. Shumaker, and E.A. Klein Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group J Urol 160 1998 39
18. N. Yavari, S. Andersson-Engels, and U. Segersten An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer Can J Urol 18 2011 5778
19. J.A. Witjes, and J. Douglass The role of hexaminolevulinate fluorescence cystoscopy in bladder cancer Nat Clin Pract Urol 4 2007 542
20. M.J. Bader, H. Stepp, and W. Beyer Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL) Urol Oncol, Epub ahead of print March 20, 2012
21. S.M. Bae, Y.W. Kim, and J.M. Lee Photodynamic effects of Radachlorin(R) on cervical cancer cells Cancer Res Treat 36 2004 389
22. Y.S. Lee, Y.C. Lim, and Y.J. Lee Photodynamic therapy for recurrent head and neck malignancy Korean J Otorhinolaryngol-Head Neck Surg 54 2011 271
23. E.V. Kochneva, E.V. Filonenko, and E.G. Vakulovskaya Photosensitizer Radachlorin(R): skin cancer PDT phase II clinical trials Photodiagnosis Photodyn Ther 7 2010 258
24. W.W. Chin, W.K. Lau, and R. Bhuvaneswari Chlorin e6-polyvinylpyrrolidone as a fluorescent marker for fluorescence diagnosis of human bladder cancer implanted on the chick chorioallantoic membrane model Cancer Lett 245 2007 127
25. M.A. D'Hallewin, and L. Baert Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder Urology 45 1995 763
26. T. Uchibayashi, K. Koshida, and K. Kunimi Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder Br J Cancer 71 1995 625
27. M.M. Walther, T.F. Delaney, and P.D. Smith Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder Urology 50 1997 199
28. M.J. Manyak, and K. Ogan Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium J Endourol 17 2003 633
29. A.P. Berger, H. Steiner, and A. Stenzl Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study Urology 61 2003 338
30. R. Waidelich, W. Beyer, and R. Knuchel Whole bladder photodynamic therapy with 5-aminolevulinic acid using a white light source Urology 61 2003 332